Long-Acting Antipsychotics

AUTHORS

Gholam Reza Mir-Sepassi 1 , * , Mehran Zarghami 2

1 Retired Associate Professor of Tehran University of Medical Sciences and Health Services, Maymanat Psychiatric Hospital, Maymanat St., Azadi Blvd., Tehran, Iran

2 Department of Psychiatry and Research Center for Psychiatry and Behavioral Sciences, Mazandaran University of Medical Sciences and Health Services, Sari, Iran

How to Cite: Mir-Sepassi G R, Zarghami M. Long-Acting Antipsychotics, Iran J Psychiatry Behav Sci. 2010 ; 4(2):1-4.

ARTICLE INFORMATION

Iranian Journal of Psychiatry and Behavioral Sciences: 4 (2); 1-4
Published Online: December 31, 2010
Article Type: Editorial
Received: March 29, 2010
Accepted: June 04, 2010
READ FULL TEXT

Abstract

Long-acting (depot) anti-psychotic injection (LAI) is an essential component of the treatment of schizophrenia. In this editorial, the journal tries to give a short account of the current ideas and practical aspects of LAI, with respect to the Iranian experience. Two categories of the Long-acting injections are discussed; mainly regarding their dosage, intervals of their injections and availabilities.

Fulltext

Full text is available in the PDF.

References

  • 1.

    References are available in the PDF.

  • © 2010, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: